2024-2025 PMHNP Review Course Manual

Please see corrections below in bold and red.

Chapter 14: Psychopharmacology: Antidepressants

Page 192:

Escitalopram (Lexapro):

Indications

FDA-approved for:

• Major Depressive Disorder (MDD) in adults and adolescents aged 12-17 years
• Generalized Anxiety Disorder (GAD) in adults
• Social Anxiety Disorder (SAD) (Changed to off-label)
• Panic Disorder (PD) in adults (Changed to off-label)
• Obsessive-Compulsive Disorder (OCD) in adults and adolescents aged 12-17 years (Changed to off-label)

Page 193:

Fluvoxamine (Luvox):

Indications

FDA-approved for:

• Obsessive-Compulsive Disorder (OCD) in adults and pediatric patients aged 8-17 years.
• Social Anxiety Disorder (SAD) in adults and pediatric patients aged 8 to 17 years. (Changed to off-label)